Follow the SPIMACO stock price and the full directors' dealings record of the company, a listed issuer based in Saudi Arabia. Shares are quoted on the SA market, under the supervision of Tadawul (CMA). Operating in the Health Care sector, SPIMACO has published 4 reports. Market capitalisation: €3.7bn. The latest transaction was reported on 24 November 2024 (Board / executive change). All data is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
SPIMACO is a company specializing in the manufacturing of pharmaceutical products and healthcare solutions. It is listed on the XSAU market.